Berlin Cures strengthens Business Advisory Board with the appointments of Ulf Berg, Ph.D., and Dragan Grabulovski, Ph.D. |
June 27, 2018 | June 2018 Bond Updates |
ZUG, Switzerland, June 27, 2018 /PRNewswire/ -- Drug developer Berlin Cures today announced the formation of a Business Advisory Board (BAB) and the appointment of its first two members, Dr. Ulf Berg and Dr. Dragan Grabulovski. The BAB's role will be to provide ongoing counsel, along with... |
View more at: https://www.prnewswire.com/news-releases/berlin-cures-strengthens-business-advisory-board-with-the-appointments-of-ulf-berg-phd-and-dragan-grabulovski-phd-300672687.html |
Related News |